Fructus Ligustri Lucidi preserves bone quality through the regulation of gut microbiota diversity, oxidative stress, TMAO and Sirt6 levels in aging mice

Aging (Albany NY). 2019 Nov 12;11(21):9348-9368. doi: 10.18632/aging.102376. Epub 2019 Nov 12.

Abstract

Gut dysbiosis and oxidative stress may trigger senile osteoporosis. Fructus Ligustri Lucidi (FLL) has bone-preserving properties and affects the intestinal microecology. However, the mechanism of the anti-osteoporotic effect of FLL and its link to the gut microbiota remains to be elucidated. Here, we demonstrated that sustained exposure of ICR mice to D-galactose / sodium nitrite for 90 days causes aging-related osteoporosis and reduced cognitive performance. The aging phenotype is also characterized by increased oxidative stress in serum. This is likely triggered by abnormal changes in the gut microbiota population of Bifidobacterium and the ratio of Firmicutes/ Bacteroidetes that resulted in increased levels of flavin-containing monooxygenase-3 and trimethylamine-N-oxide (TMAO). Moreover, the increased oxidative stress further accelerated aging by increasing tumor necrosis factor-α levels in serum and reducing Sirtuin 6 (Sirt6) expression in long bones, which prompted nuclear factor kappa-B acetylation as well as over-expression and activation of cathepsin K. FLL-treated aging mice revealed a non-osteoporotic bone phenotype and an improvement on the cognitive function. The mechanism underlying these effects may be linked to the regulation of gut microbiota diversity, antioxidant activity, and the levels of TMAO and Sirt6. FLL may represent a potential source for identifying anti-senile osteoporotic drug candidates.

Keywords: TMAO; fructus ligustri lucidi; gut microbiota; oxidative stress; senile osteoporosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging / drug effects
  • Animals
  • Bone and Bones / drug effects*
  • Bone and Bones / metabolism
  • Cathepsin K / metabolism
  • Cognitive Dysfunction / chemically induced
  • Cognitive Dysfunction / drug therapy
  • Drug Evaluation, Preclinical
  • Galactose
  • Gastrointestinal Microbiome / drug effects*
  • Ligustrum*
  • Male
  • Methylamines / blood
  • Mice, Inbred ICR
  • NF-kappa B / metabolism
  • Osteoporosis / chemically induced
  • Osteoporosis / prevention & control*
  • Oxidative Stress / drug effects
  • Phytotherapy
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • Signal Transduction / drug effects
  • Sirtuins / metabolism
  • Sodium Nitrite

Substances

  • Methylamines
  • NF-kappa B
  • Plant Extracts
  • Sirt6 protein, mouse
  • Cathepsin K
  • Ctsk protein, mouse
  • Sirtuins
  • trimethyloxamine
  • Sodium Nitrite
  • Galactose